Holdings of the Fund as of 5/17/2024
Total Number of Holdings (excluding cash): 50
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
3,104 |
$87,297.40 |
2.76% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
1,180 |
$75,992.00 |
2.40% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
48 |
$73,092.00 |
2.31% |
| Hoya Corporation |
7741.JP |
J22848105 |
594 |
$72,310.47 |
2.29% |
| ResMed Inc. |
RMD |
761152107 |
328 |
$71,690.96 |
2.27% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,340 |
$70,857.43 |
2.24% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
13,578 |
$70,387.70 |
2.23% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
3,912 |
$69,401.42 |
2.20% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
217 |
$69,566.11 |
2.20% |
| Steris Plc |
STE |
G8473T100 |
299 |
$69,574.31 |
2.20% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,826 |
$68,218.63 |
2.16% |
| Danaher Corporation |
DHR |
235851102 |
254 |
$67,513.20 |
2.14% |
| Waters Corporation |
WAT |
941848103 |
189 |
$67,274.55 |
2.13% |
| Boston Scientific Corporation |
BSX |
101137107 |
896 |
$66,886.40 |
2.12% |
| Agilent Technologies, Inc. |
A |
00846U101 |
433 |
$66,781.59 |
2.11% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
5,101 |
$66,344.00 |
2.10% |
| Alcon Inc. |
ALC.SW |
H01301128 |
749 |
$66,031.72 |
2.09% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,734 |
$65,928.87 |
2.09% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,342 |
$65,514.49 |
2.07% |
| Medtronic Plc |
MDT |
G5960L103 |
761 |
$65,385.12 |
2.07% |
| Cochlear Limited |
COH.AU |
Q25953102 |
295 |
$65,267.38 |
2.06% |
| Insulet Corporation |
PODD |
45784P101 |
348 |
$65,169.96 |
2.06% |
| Revvity, Inc. |
RVTY |
714046109 |
589 |
$64,925.47 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
108 |
$64,292.40 |
2.03% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
159 |
$63,412.38 |
2.01% |
| The Cooper Companies, Inc. |
COO |
216648501 |
652 |
$63,446.12 |
2.01% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,560 |
$62,284.92 |
1.97% |
| Teleflex Incorporated |
TFX |
879369106 |
284 |
$61,809.76 |
1.96% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,074 |
$61,751.10 |
1.95% |
| Becton, Dickinson and Company |
BDX |
075887109 |
259 |
$61,201.70 |
1.94% |
| Shockwave Medical, Inc. |
SWAV |
82489T104 |
186 |
$61,404.18 |
1.94% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
676 |
$60,258.64 |
1.91% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
203 |
$59,651.55 |
1.89% |
| Stryker Corporation |
SYK |
863667101 |
178 |
$59,573.04 |
1.88% |
| Hologic, Inc. |
HOLX |
436440101 |
789 |
$59,190.78 |
1.87% |
| DexCom, Inc. |
DXCM |
252131107 |
448 |
$58,849.28 |
1.86% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
472 |
$58,465.68 |
1.85% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
561 |
$58,130.60 |
1.84% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
707 |
$57,875.02 |
1.83% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
481 |
$57,806.58 |
1.83% |
| Abbott Laboratories |
ABT |
002824100 |
553 |
$57,561.77 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
549 |
$57,245.31 |
1.81% |
| Penumbra, Inc. |
PEN |
70975L107 |
280 |
$56,988.40 |
1.80% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
160 |
$56,902.40 |
1.80% |
| Masimo Corporation |
MASI |
574795100 |
442 |
$54,852.20 |
1.74% |
| Baxter International Inc. |
BAX |
071813109 |
1,512 |
$53,298.00 |
1.69% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
391 |
$52,278.25 |
1.65% |
| Align Technology, Inc. |
ALGN |
016255101 |
189 |
$51,313.50 |
1.62% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
229 |
$49,001.52 |
1.55% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
855 |
$43,074.90 |
1.36% |
| US Dollar |
$USD |
|
6,196 |
$6,196.44 |
0.20% |
| Japanese Yen |
$JPY |
|
282,400 |
$1,813.63 |
0.06% |
| Euro |
$EUR |
|
-13 |
($14.51) |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.06 |
0.00% |
| Swiss Franc |
$CHF |
|
0 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|